Humira-cd/uc/hs Starter
My Prescription
Payment
Select pharmacy
$6,313.14
$30.00 due at pharmacy
$6,313.14 - $30.00 = $6,283.14
$6,283.14 remaining balance
You will be given your coupon after you complete your purchase with PayPal.
WalgreensPowered by$6,313.14
Print or send this coupon to your phone
WalgreensPowered byAbout Humira-cd/uc/hs Starter
Drug Details
Adalimumab is a medication designed to alleviate pain and swelling associated with various types of arthritis, including rheumatoid, psoriatic, juvenile idiopathic, and ankylosing spondylitis. Additionally, it treats certain skin disorders like plaque psoriasis and hidradenitis suppurativa. The drug functions by inhibiting a protein called tumor necrosis factor (TNF) in the immune system, which is responsible for causing joint inflammation and damage, as well as the red, scaly patches seen in psoriasis. As a member of the TNF blockers drug class, Adalimumab helps to decrease joint swelling, thereby preventing further damage and preserving joint function. It is also effective in treating specific bowel conditions, such as Crohn's disease and ulcerative colitis, as well as uveitis, a type of eye disease. This description covers various formulations of Adalimumab, including adalimumab, adalimumab-aacf, adalimumab-aaty, adalimumab-adaz, adalimumab-adbm, adalimumab-afzb, adalimumab-aqvh, adalimumab-atto, adalimumab-bwwd, adalimumab-fkjp, and adalimumab-ryvk.
Price history for Humira-cd/uc/hs Starter
1 Auto-injector Kit, 80MG/0.8ML
Average retail price for Humira-cd/uc/hs Starter
Average SaveHealth price for Humira-cd/uc/hs Starter
Our price history data is based on aggregated prescription data collected from participating pharmacies in America. Our prescription data updates daily to reflect the latest price changes. If you notice a missing data point, it means there wasn't sufficient data available to generate a monetary value for that date.
*Retail prices are based on pharmacy claims data, and may not be accurate when we don't have enough claims.
Humira-cd/uc/hs Starter dosage forms
| Dosage | Quantity | Price from | Per unit |
|---|---|---|---|
| 40MG/0.8ML | 1 Auto-injector Kit | $3,580.09 | $3,580.09 |
| 40MG/0.8ML | 2 Auto-injector Kits | $7,152.17 | $3,576.09 |
| 40MG/0.8ML | 3 Auto-injector Kits | $10,724.26 | $3,574.75 |
| 80MG/0.8ML | 1 Auto-injector Kit | $6,313.14 | $6,313.14 |
| 80MG/0.8ML | 2 Auto-injector Kits | $12,621.52 | $6,310.76 |
| 80MG/0.8ML | 3 Auto-injector Kits | $18,929.91 | $6,309.97 |
Humira-cd/uc/hs Starter FAQs
The cost of the HUMIRA starter pack can vary significantly based on factors such as insurance coverage, pharmacy location, and any available discounts or assistance programs. Without insurance, the price can be quite high, often exceeding several thousand dollars. Patients are encouraged to check with their insurance provider and explore patient assistance programs offered by the manufacturer to potentially reduce out-of-pocket costs.
The most common side effect of HUMIRA (adalimumab) is injection site reactions, which can include redness, itching, pain, or swelling at the site of the injection.
There are several options for obtaining HUMIRA at a reduced cost or for free. Patients may consider the following:1. **Patient Assistance Programs**: AbbVie, the manufacturer of HUMIRA, offers a patient assistance program called "myAbbVie Assist" for eligible patients who are uninsured or underinsured. This program may provide HUMIRA at no cost to those who qualify.2. **Insurance Coverage**: Patients should check with their insurance provider to understand their coverage options for HUMIRA. Some insurance plans may cover the medication fully or partially.3. **Non-Profit Organizations**: Organizations such as the Patient Access Network Foundation or the HealthWell Foundation may offer financial assistance to help cover the cost of HUMIRA for eligible patients.4. **Healthcare Provider**: Patients should discuss with their healthcare provider, who may have additional resources or suggestions for obtaining HUMIRA at a reduced cost.Eligibility for these programs typically depends on factors such as income, insurance status, and medical need. It is advisable for patients to contact these programs directly for more detailed information and to apply.
Humira (adalimumab) can have neurological side effects, although they are relatively rare. These may include headaches, dizziness, and in some cases, demyelinating disorders such as multiple sclerosis-like symptoms. Patients experiencing any unusual neurological symptoms should contact their healthcare provider for further evaluation.
The success rate of HUMIRA (adalimumab) for patients with hidradenitis suppurativa (HS) varies, but clinical trials have shown that approximately 50% of patients achieve a significant reduction in the number of abscesses and inflammatory nodules after 12 weeks of treatment. Individual responses can vary, and it is important for patients to discuss their specific case with their healthcare provider.